Objective: We analysed the Trent Hepatitis C cohort to determine standardised mortality ratios in patients infected with hepatitis C virus, and to identify risk factors and associations with all-cause and liver- related mortality.
Design: Cohort study.
Setting: Patients with hepatitis C virus infection attending secondary care within the Trent region of England.
Patients: 2285 patients with hepatitis C, followed for one year or more.
Main outcome measures: The death rate in the cohort was compared to that seen in an age and sex matched English population. We performed Cox regression analyses to identify factors predictive of all-cause mortality and deaths from liver disease.
Results: Standardised mortality ratios in the cohort were 3 times higher than those expected in the population of England. The excess deaths were due to liver-related causes and those associated with a drug- using lifestyle. Significant independent predictors of all-cause mortality were age, sex, treatment (protective) and liver biopsy fibrosis. For liver-related mortality age, treatment, liver biopsy fibrosis and mean alcohol consumption were predictors. HCV was mentioned on 23% of death certificates overall, and 52% of those from patients dying of a liver-related cause.
Conclusions: Our findings demonstrate that the death rate in patients infected with hepatitis C is 3 times higher than expected. Severity of disease is associated with a worse prognosis whilst treatment improves outcome, particularly in those who respond. Use of death certificate data on HCV infection for planning purposes will result in considerable under-estimation of the HCV-related disease burden.
- Hepatitis C virus
- Mortality rates
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.